Clinical experience of saibokuto and ethyl loflazepate (Meilax) for the temporomandibular arthrosis.

DOI
  • Miyoshi Norihiro
    Department of Oral and Maxillofacial Surgery I, Okayama University Dental School
  • Nishijima Yutaka
    Department of Oral and Maxillofacial Surgery I, Okayama University Dental School
  • Kobayashi Hiroharu
    Department of Oral and Maxillofacial Surgery I, Okayama University Dental School Clinic for the Handicapped patients and Specific disease, Okayama University Dental Hospital
  • Nishijima Katsumi
    Department of Oral and Maxillofacial Surgery I, Okayama University Dental School Clinic for the Handicapped patients and Specific disease, Okayama University Dental Hospital

Bibliographic Information

Other Title
  • 顎関節症に対する柴朴湯およびＥｔｈｙｌ　ｌｏｆｌａｚｅｐａｔｅ（メイラックス）の使用経験

Search this article

Description

The present study concerns the effectiveness of Saibokuto or ethyl loflazepate (Meilax®) in patients with temporomandibular arthrosis and apparently requiring a treatment from the psychological standpoint.<BR>The two cases received Meilax were markedly improved. In addition, no side effect was observed following the administration of Saibokuto or Meilax.

Journal

Keywords

Details 詳細情報について

  • CRID
    1390001204342549120
  • NII Article ID
    130004308113
  • DOI
    10.11268/jjpsd1986.4.24
  • ISSN
    21864128
    09136681
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top